MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with C

Cyclophosphamide

Cyclophosphamide 25mg tablets

Incompatible

Stability notes for Cyclophosphamide 25mg tablets

Cytotoxic medicine. Not recommended due to handler risk.

Suppliers

Cyclophosphamide 25mg tablets (Special Order)
Cytoxan 25mg tablets (Imported (United States))

Cyclophosphamide 50mg tablets

Incompatible

Stability notes for Cyclophosphamide 50mg tablets

Cytotoxic medicine. Not recommended due to handler risk.

Suppliers

Cyclophosphamide 50mg tablets (Alliance Healthcare (Distribution) Ltd)
Cyclophosphamide 50mg tablets (Baxter Healthcare Ltd)
Cyclophosphamide 50mg tablets (CST Pharma Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.